Celularity, Inc. CELU
1.38
0.06
4.55%
as of 25 Sep
- Market cap
- $38.2M
- P/E
- 0.0×
Follow CELU
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 | 0.00 | 11.45 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | 0.00 | 16.09 | 8.80 | 2.19 | 0.84 | 1.07 |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | (12.04) | (10.71) | (5.34) | (11.49) | 28.57 | (5.57) |
P/B ratio |
— | — | — | 0.00 | 3.45 | 0.79 | 1.22 | 5.15 | 0.00 |
Price to Tangible BV |
— | — | — | 0.00 | 0.00 | 0.00 | 2.21 | 0.00 | 0.00 |
EV/Sales |
— | — | — | 0.00 | 15.81 | 11.67 | 5.05 | 1.61 | 2.64 |
EV/EBITDA |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | (2.78) | (3.06) | (1.52) | (2.97) | (13.60) | (5.29) |
EV/FCF |
— | — | — | (2.78) | (2.90) | (1.47) | (2.89) | (13.27) | (5.22) |
Quick Ratio |
— | 0.16 | 4.00 | 2.28 | 1.62 | 0.34 | 0.18 | 0.27 | 0.13 |
Current Ratio |
— | 0.16 | 4.41 | 2.71 | 2.25 | 0.54 | 0.29 | 0.38 | 0.15 |
Net Debt/EBITDA |
— | (113.91) | 0.54 | 1.66 | 0.06 | (4.11) | (0.55) | (1.37) | (0.77) |
Debt/Assets |
0.00% | 85.96% | 0.00% | 7.11% | 7.52% | 16.35% | 27.27% | 31.87% | 44.55% |
Debt/Equity |
— | 6.28 | 0.00 | 1.64 | 0.31 | 0.33 | 0.96 | 4.79 | (1.26) |
Asset Turnover |
— | 0.00 | 0.00 | 0.04 | 0.05 | 0.04 | 0.08 | 0.39 | 0.22 |
Operating CF/Net income |
— | 0.45 | (0.19) | 0.30 | 1.10 | (9.72) | 0.20 | 0.11 | 0.14 |
Capex/Depreciation |
— | — | — | (0.20) | (0.70) | (0.40) | (0.01) | (0.02) | 0.00 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 0.00% | 234.03% | 79.12% | 46.35% | 9.51% | (163.67%) | (232.51%) | 628.23% | |
| — | (1.26%) | 4.03% | (57.63%) | (23.69%) | 3.48% | (72.04%) | (41.86%) | (76.50%) | |
ROIC |
— | (0.46%) | (25.77%) | 0.00% | (73.05%) | (6.39%) | (150.27%) | (47.58%) | (1,070.92%) |
Return on Tangible Assets |
— | 0.87% | 753.60% | (153.61%) | (81.07%) | 30.15% | (965.88%) | (203.27%) | 726.09% |
Average Days of Receivables |
— | — | — | 167.44 | 89.53 | 141.45 | 194.24 | 91.26 | 63.97 |
Research and Development Expense of Revenue |
— | — | — | 369.15% | 414.12% | 435.96% | 133.79% | 32.07% | 56.59% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 219.47% | 334.38% | 367.29% | 222.11% | 108.16% | 193.09% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.58 | 0.60 | 0.60 | 0.13 | 0.13 | 0.14 |
Share Based Compensation of Revenue |
— | — | 0.00% | 30.61% | 187.53% | 88.21% | 65.95% | 21.34% | 39.09% |
Graham Net Nets |
— | — | — | (1.68) | (0.74) | (1.07) | (1.67) | (2.27) | (4.68) |
Graham Number |
— | — | — | 856.71 | 0.00 | 17.77 | 0.00 | 0.00 | 10.95 |
Earnings Yield |
— | — | — | (102.78%) | (110.33%) | 8.73% | (392.81%) | (127.40%) | (323.11%) |
Free Cash Flow Yield |
— | — | — | (31.19%) | (33.87%) | (90.52%) | (79.66%) | (14.41%) | (47.21%) |
Revenue per Share |
— | 0.00 | 0.00 | 7.75 | 3.18 | 1.28 | 1.28 | 2.48 | 1.04 |
Operating CF per Share |
— | 0.00 | (1.21) | (34.31) | (16.42) | (9.85) | (2.17) | (0.29) | (0.52) |
Capex per Share |
— | 0.00 | 0.00 | (15.11) | (0.92) | (0.37) | (0.06) | (0.01) | 0.00 |
Free Cash Flow per Share |
— | 0.00 | (1.21) | (49.42) | (17.34) | (10.23) | (2.23) | (0.30) | (0.52) |
Cash per Share |
— | 0.03 | 1.01 | 29.49 | 5.55 | 1.00 | 0.01 | 0.03 | 0.24 |
Shareholders Equity per Share |
— | 0.03 | 5.50 | 10.16 | 14.83 | 14.22 | 2.30 | 0.40 | (1.49) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.03 | 5.50 | 10.16 | 14.83 | 14.22 | 2.30 | 0.40 | (1.49) |
Free Cash Flow |
— | 0.00 | (1.10) | (91.03) | (116.30) | (143.11) | (39.73) | (6.56) | (13.25) |
Working Capital |
— | (0.13) | 0.78 | 45.48 | 32.88 | (28.59) | (47.50) | (33.12) | (68.44) |
Capital Expenditures |
— | — | — | (27.83) | (6.20) | (5.24) | (1.05) | (0.16) | — |
Net Current Asset Value |
— | (0.13) | (285.60) | (340.13) | (255.61) | (168.66) | (83.14) | (103.28) | (133.07) |
EV/EBIT |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | 1.95 | 0.29 | 0.29 | 0.05 | 0.00 | 0.00 |
Net Profit Margin |
— | 0.00% | 0.00% | (1,458.42%) | (469.27%) | 78.95% | (862.04%) | (106.77%) | (345.76%) |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | — | — | 1.53 | 0.10 | 0.17 | 1.79 | 0.13 | 0.13 |
Cash ROIC |
— | (0.25%) | (18.55%) | (147.85%) | (119.62%) | (76.68%) | (132.43%) | (131.12%) | (433.52%) |
Accounts Receivable Turnover |
— | — | — | 2.42 | 3.62 | 2.95 | 2.39 | 4.22 | 2.92 |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 1.76 | 1.31 | 2.60 | 1.61 | 0.80 | 0.81 |
Inventory Turnover |
— | — | — | 0.74 | 1.44 | 2.65 | 2.90 | 2.69 | 6.71 |
Average Days of Payables |
— | 0.00 | 0.00 | 398.90 | 352.30 | 107.84 | 322.34 | 567.29 | 480.42 |
Days of Inventory on Hand |
— | — | — | 284.93 | 361.07 | 98.52 | 131.11 | 131.72 | 10.38 |
Average Receivables |
— | — | — | 5.89 | 5.89 | 6.10 | 9.54 | 12.84 | 9.11 |
Average Payables |
— | 0.11 | 0.11 | 2.80 | 7.35 | 7.56 | 9.98 | 18.72 | 24.86 |
Average Inventory |
— | — | — | 6.70 | 6.70 | 7.43 | 5.53 | 5.58 | 2.99 |
Average Assets |
— | 0.09 | 145.89 | 361.31 | 422.57 | 407.60 | 272.48 | 138.29 | 120.01 |
Average Common Equity |
— | 131.71 | 2.51 | (263.20) | (215.99) | 149.16 | 119.93 | 24.90 | (14.61) |
Columns are period end dates